Net profit of ERIS Lifesciences rose 41.63% to Rs 117.99 crore in the quarter ended June 2025 as against Rs 83.31 crore during the previous quarter ended June 2024. Sales rose 7.82% to Rs 771.56 crore in the quarter ended June 2025 as against Rs 715.59 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 771.56 | 715.59 | 8 |
OPM % | 35.86 | 34.93 | - |
PBDT | 231.61 | 191.26 | 21 |
PBT | 161.10 | 115.52 | 39 |
NP | 117.99 | 83.31 | 42 |